Newly Diagnosed Acute Myeloid Leukemia (AML)
6 clinical trials · Condition
◉ Watch Newly Diagnosed Acute Myeloid Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) (NCT05445154) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-31 |
| Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid Leukemia (NCT04250051) | Northwestern University | 2020-12-21 |
| Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation (NCT03173248) | Institut de Recherches Internationales Servier | 2017-06-26 |
| Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation (NCT02632708) | Institut de Recherches Internationales Servier | 2015-12-31 |
Track Newly Diagnosed Acute Myeloid Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.